Gilpin Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$162K Buy
420
+314
+296% +$116K 0.11% 148
2026
Q1
$31K Buy
106
+41
+63% +$13.5K 0.02% 222
2025
Q4
$22.8K Buy
+65
New +$22K 0.02% 228

Other funds holding ELV

Gilpin Wealth Management's ELV Position: Q2 2026 in Review

Gilpin Wealth Management increased its Elevance Health (ELV) stake by 296% in Q2 2026, buying an estimated $116K and bringing the position to 420 shares worth $162K. The position accounts for 0.11% of the portfolio, ranked #148.

Gilpin Wealth Management first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Gilpin Wealth Management held 420 shares of Elevance Health worth $162K as of Q2 2026.
  • Gilpin Wealth Management bought 314 Elevance Health shares in Q2 2026, an estimated $116K.
  • Elevance Health made up 0.11% of Gilpin Wealth Management's portfolio in Q2 2026, its #148 holding.
  • Gilpin Wealth Management first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Gilpin Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.